Clinical Trial Update: Optimal LDL-C Target in High-risk Patients After PCI [NA]

View source ↗

Summary

A clinical trial update investigating the optimal LDL-C target in high-risk patients after percutaneous coronary intervention, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Xijing Hospital | Conditions: Chronic Coronary Syndrome, Acute Coronary Syndromes | NA | Status: NOT_YET_RECRUITING